3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial - The Lancet Psychiatry
Ecstasy as a Remedy for PTSD? You Probably Have Some Questions. - The New York Times
All clear for the decisive trial of ecstasy in PTSD patients | Science | AAAS
Why Psychedelics? | Stanford Psychedelic Science Group | Stanford Medicine
MDMA-assisted psychotherapy could be a game-changer for treating PTSD | PhillyVoice
MDMA for PTSD - MAPS PBC - Psychedelic Therapy
FDA Designates MDMA As 'Breakthrough Therapy' For Post-Traumatic Stress
Psychedelics and the Future of Psychiatry
MAPS' Phase 3 Trial of MDMA-Assisted Therapy for PTSD Achieves Successful Results for Patients with Severe, Chronic PTSD - Multidisciplinary Association for Psychedelic Studies - MAPS
Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial | PLOS ONE
Party drug' MDMA touted as breakthrough therapy for PTSD patients - National | Globalnews.ca
First Phase 3 trial data for MDMA therapy sets path for approval
MAPS Study: MDMA-Assisted Psychotherapy Will Be More Cost-Effective than Other Treatments for PTSD
Latest trials confirm the benefits of MDMA – the drug in ecstasy – for treating PTSD
MDMA for PTSD - Apply for Clinical Trials - Sponsored by MAPS
MDMA for PTSD study: Veteran shares experience
Latest Trials Confirm the Benefits of MDMA - the Drug in Ecstasy - for Treating PTSD - UConn Today
First Phase 3 trial data for MDMA therapy sets path for approval
Could ECSTASY cure PTSD? Patients given party drug before counselling respond better to treatment | Daily Mail Online
Frontiers | Couple Therapy With MDMA—Proposed Pathways of Action | Psychology
A Psychedelic May Soon Go to the FDA for Approval to Treat Trauma - Scientific American
MDMA for PTSD - MAPS PBC - Psychedelic Therapy
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo- controlled phase 3 study | Nature Medicine
MAPS' Phase 3 Trial of MDMA-Assisted Therapy for PTSD Achieves Successful Results for Patients with Severe, Chronic PTSD - Multidisciplinary Association for Psychedelic Studies - MAPS
